Inventor
LEE RICHARD T
US37 patents
⚠️ This page may combine multiple inventors who share the name “LEE RICHARD T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRIGHAM & WOMENS HOSPITAL
13 patentsUS7670769B2Mar 2, 2010
IL1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL53 citations98
US7432060B2Oct 7, 2008
Methods for diagnosis of cardiovascular disease
BRIGHAM & WOMENS HOSPITAL57 citations98
US8871452B2Oct 28, 2014
Methods for treatment of cardiovascular disease
BRIGHAM & WOMENS HOSPITAL31 citations96
US8748116B2Jun 10, 2014
1L1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL25 citations96
US8734769B2May 27, 2014
1L1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL31 citations96
US7989210B2Aug 2, 2011
IL1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL41 citations96
US7985558B2Jul 26, 2011
Methods for diagnosis of cardiovascular disease
BRIGHAM & WOMENS HOSPITAL42 citations96
US7655415B2Feb 2, 2010
IL1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL45 citations96
US5584879ADec 17, 1996
Aortic valve supporting device
BRIGHAM & WOMENS HOSPITAL314 citations93
US7429567B2Sep 30, 2008
Sustained delivery of PDGF using self-assembling peptide nanofibers
BRIGHAM & WOMENS HOSPITAL21 citations86
US7399831B2Jul 15, 2008
Targeted delivery of biological factors using self-assembling peptide nanofibers
BRIGHAM & WOMENS HOSPITAL12 citations84
US5236693AAug 17, 1993
Medical ultrasound contrast agent and method of using same
BRIGHAM & WOMENS HOSPITAL10 citations74
US7999067B2Aug 16, 2011
Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
BRIGHAM & WOMENS HOSPITAL5 citations71
BRIGHAM & WOMENS HOSPITAL INC
9 patentsUS9857379B2Jan 2, 2018
Methods for treatment of cardiovascular disease
BRIGHAM & WOMENS HOSPITAL INC6 citations84
US9434779B2Sep 6, 2016
Growth differentiation factor 11 (GDF-11) for treatment of diastolic heart failure
BRIGHAM & WOMENS HOSPITAL INC8 citations79
US10788500B2Sep 29, 2020
IL1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL INC1 citations73
US9851362B2Dec 26, 2017
1L1RL-1 as a cardiovascular disease marker and therapeutic target
BRIGHAM & WOMENS HOSPITAL INC2 citations73
US9631005B2Apr 25, 2017
Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
BRIGHAM & WOMENS HOSPITAL INC2 citations70
US9790264B2Oct 17, 2017
Compounds and methods for modulating pharmacokinetics
BRIGHAM & WOMENS HOSPITAL INC2 citations68
US9421245B2Aug 23, 2016
Targeted therapeutics
BRIGHAM & WOMENS HOSPITAL INC5 citations68
US10774124B2Sep 15, 2020
Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
BRIGHAM & WOMENS HOSPITAL INC0 citations49
US9637531B2May 2, 2017
Selective cartilage therapy
BRIGHAM & WOMENS HOSPITAL INC0 citations47
HARVARD COLLEGE
5 patentsUS11612639B2Mar 28, 2023
Methods and compositions for rejuvenating skeletal muscle stem cells
HARVARD COLLEGE2 citations72
US10092627B2Oct 9, 2018
Methods and compositions for rejuvenating skeletal muscle stem cells
HARVARD COLLEGE5 citations72
US11890321B2Feb 6, 2024
Method of treating or inhibiting glucose intolerance
HARVARD COLLEGE0 citations56
US10980857B2Apr 20, 2021
Treatment with GDF11 prevents weight gain, improves glucose tolerance and reduces hepatosteatosis
HARVARD COLLEGE1 citations56
US11850266B2Dec 26, 2023
Cardiomyocytes and compositions and methods for producing the same
HARVARD COLLEGE0 citations55
LEE RICHARD T
3 patentsUS8597958B2Dec 3, 2013
IL1RL-1 as a cardiovascular disease marker and therapeutic target
LEE RICHARD T35 citations97
US8530173B2Sep 10, 2013
Methods for treatment of cardiovascular disease
LEE RICHARD T35 citations97
US8147817B2Apr 3, 2012
IL-33 in the treatment and diagnosis of diseases and disorders
LEE RICHARD T19 citations92